Rosalind Advisors »

Onkure Therapeutics Inc-a shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.1M 731k 2.90

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Savara (SVRA)
Fennec Pharmaceuticals (FENC)
Xeris Pharmaceuticals (XERS)
Miragen Therapeutics (VRDN)
Mediwound Shs New (MDWD)
Verastem Com New (VSTM)
Replimune Group (REPL)
Atyr Pharma (ATYR)
Cybin Com New (HELP)
Eyepoint Pharmaceuticals Com New (EYPT)
Cg Oncology (CGON)
Cytokinetics Com New (CYTK)
X4 Pharmaceuticals Com New (XFOR)
Mind Medicine Mindmed Com New (MNMD)

View all positions for Rosalind Advisors

Top funds holding Onkure Therapeutics Inc-a

Acorn Capital Advisors
Citadel Advisors
ADAR1 Capital Management
Prosight Management
None
Rosalind Advisors
Vestal Point Capital
Vanguard Group
Highbridge Capital Management
StepStone
NEA Management Company
Cantor Fitzgerald, L. P.
Carlyle
Renaissance Technologies
Rangeley Capital

View all funds holding Onkure Therapeutics Inc-a